Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, 06 1996, 1476-1481, Vol 40, No. 6
F Frappier, A Jossang, J Soudon, F Calvo, P Rasoanaivo, S Ratsimamanga-Urverg, J Saez, J Schrevel and P Grellier
Ten naturally occurring bisbenzylisoquinolines (BBIQ) and two dihydro
derivatives belonging to five BBIQ subgroups were evaluated in vitro for
their ability to inhibit Plasmodium falciparum growth and, in drug
combination, to reverse the resistance to chloroquine of strain FcB1. The
same alkaloids were also assessed in vitro for their potentiating activity
against vinblastine with the multidrug-resistant clone CCRF- CEM/VLB,
established from lymphoblastic acute leukemia. Three of the BBIQ tested had
50% inhibitory concentrations of less than 1 microM. The most potent
antimalarial agent was cocsoline (50% inhibitory concentration, 0.22
microM). Regarding the chloroquine-potentiating effect, fangchinoline
exhibited the highest biological activity whereas the remaining compounds
displayed either antagonistic or slight synergistic effects. Against the
multidrug-resistant cancer cell line, fangchinoline was also by far the
most active compound. Although there were clear differences between the
activities of tested alkaloids, no relevant structure-activity relationship
could be established. Nevertheless, fangchinoline appears to be a new
biochemical tool able to help in the comprehension of the mechanism of both
chloroquine resistance in P. falciparum and multidrug resistance in tumor
cells.
Copyright © 1996 by the American Society for Microbiology. All rights reserved.
Bisbenzylisoquinolines as modulators of chloroquine resistance in Plasmodium falciparum and multidrug resistance in tumor cells
Institut Malgache de Recherches Appliquees, Madagascar.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»